To explore whether there are m6A modification sites on UBXN1 mRNA that have the potential to be recognized by YTHDF2 in glioma cells, we performed MeRIP sequencing in GBM patient-derived N33 cells. The gene discussed is YTHDF2; the disease is central nervous system cancer.